S932 Active Tuberculosis and Opportunistic Infections: Pooled Safety Analysis of Ustekinumab Through up to 5 Years Across All Approved Indications

Subrata Ghosh

doi:10.14309/01.ajg.0000860368.55128.7d

S932 Active Tuberculosis and Opportunistic Infections: Pooled Safety Analysis of Ustekinumab Through up to 5 Years Across All Approved Indications

Subrata Ghosh

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	American Journal of Gastroenterology
DOIs	https://doi.org/10.14309/01.ajg.0000860368.55128.7d
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Medicine
Ustekinumab
Concomitant
Internal medicine
Bristol-Myers
Psoriatic arthritis
Tuberculosis
Inflammatory bowel disease
Ulcerative colitis
Psoriasis
Surgery
Gastroenterology
Adalimumab
Disease
Dermatology
Pathology

Access to Document

10.14309/01.ajg.0000860368.55128.7d

https://openalex.org/W4316086191Licence: CC BY-NC-ND

Cite this

@article{35aa9356bd0f434ea9c252910ddbb47c,

title = "S932 Active Tuberculosis and Opportunistic Infections: Pooled Safety Analysis of Ustekinumab Through up to 5 Years Across All Approved Indications",

keywords = "Medicine, Ustekinumab, Concomitant, Internal medicine, Bristol-Myers, Psoriatic arthritis, Tuberculosis, Inflammatory bowel disease, Ulcerative colitis, Psoriasis, Surgery, Gastroenterology, Adalimumab, Disease, Dermatology, Pathology",

author = "Subrata Ghosh",

year = "2022",

doi = "10.14309/01.ajg.0000860368.55128.7d",

language = "English",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Wolters Kluwer Health",

}

TY - JOUR

T1 - S932 Active Tuberculosis and Opportunistic Infections: Pooled Safety Analysis of Ustekinumab Through up to 5 Years Across All Approved Indications

AU - Ghosh, Subrata

PY - 2022

Y1 - 2022

KW - Medicine

KW - Ustekinumab

KW - Concomitant

KW - Internal medicine

KW - Bristol-Myers

KW - Psoriatic arthritis

KW - Tuberculosis

KW - Inflammatory bowel disease

KW - Ulcerative colitis

KW - Psoriasis

KW - Surgery

KW - Gastroenterology

KW - Adalimumab

KW - Disease

KW - Dermatology

KW - Pathology

U2 - 10.14309/01.ajg.0000860368.55128.7d

DO - 10.14309/01.ajg.0000860368.55128.7d

M3 - Article

SN - 0002-9270

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

ER -